165 related articles for article (PubMed ID: 37365321)
1. Genome-wide association study identifies novel susceptibilities to adult moyamoya disease.
Jeon JP; Hong EP; Ha EJ; Kim BJ; Youn DH; Lee S; Lee HC; Kim KM; Lee SH; Cho WS; Kang HS; Kim JE
J Hum Genet; 2023 Oct; 68(10):713-720. PubMed ID: 37365321
[TBL] [Abstract][Full Text] [Related]
2. A genome-wide association study identifies RNF213 as the first Moyamoya disease gene.
Kamada F; Aoki Y; Narisawa A; Abe Y; Komatsuzaki S; Kikuchi A; Kanno J; Niihori T; Ono M; Ishii N; Owada Y; Fujimura M; Mashimo Y; Suzuki Y; Hata A; Tsuchiya S; Tominaga T; Matsubara Y; Kure S
J Hum Genet; 2011 Jan; 56(1):34-40. PubMed ID: 21048783
[TBL] [Abstract][Full Text] [Related]
3. Novel Susceptibility Loci for Moyamoya Disease Revealed by a Genome-Wide Association Study.
Duan L; Wei L; Tian Y; Zhang Z; Hu P; Wei Q; Liu S; Zhang J; Wang Y; Li D; Yang W; Zong R; Xian P; Han C; Bao X; Zhao F; Feng J; Liu W; Cao W; Zhou G; Zhu C; Yu F; Yang W; Meng Y; Wang J; Chen X; Wang Y; Shen B; Zhao B; Wan J; Zhang F; Zhao G; Xu A; Zhang X; Liu J; Zuo X; Wang K
Stroke; 2018 Jan; 49(1):11-18. PubMed ID: 29273593
[TBL] [Abstract][Full Text] [Related]
4. The Role of RNF213 4810G>A and 4950G>A Variants in Patients with Moyamoya Disease in Korea.
Park YS; An HJ; Kim JO; Kim WS; Han IB; Kim OJ; Kim NK; Kim DS
Int J Mol Sci; 2017 Nov; 18(11):. PubMed ID: 29160859
[TBL] [Abstract][Full Text] [Related]
5. RNF213 as the major susceptibility gene for Chinese patients with moyamoya disease and its clinical relevance.
Zhang Q; Liu Y; Zhang D; Wang R; Zhang Y; Wang S; Yu L; Lu C; Liu F; Zhou J; Zhang X; Zhao J
J Neurosurg; 2017 Apr; 126(4):1106-1113. PubMed ID: 27128593
[TBL] [Abstract][Full Text] [Related]
6. Importance of RNF213 polymorphism on clinical features and long-term outcome in moyamoya disease.
Kim EH; Yum MS; Ra YS; Park JB; Ahn JS; Kim GH; Goo HW; Ko TS; Yoo HW
J Neurosurg; 2016 May; 124(5):1221-7. PubMed ID: 26430847
[TBL] [Abstract][Full Text] [Related]
7. RNF213 rs112735431 polymorphism in intracranial artery steno-occlusive disease and moyamoya disease in Koreans.
Park MG; Shin JH; Lee SW; Park HR; Park KP
J Neurol Sci; 2017 Apr; 375():331-334. PubMed ID: 28320162
[TBL] [Abstract][Full Text] [Related]
8. Genetic analysis of
Tashiro R; Fujimura M; Sakata H; Endo H; Tomata Y; Sato-Maeda M; Niizuma K; Tominaga T
Neurol Res; 2019 Sep; 41(9):811-816. PubMed ID: 31064275
[No Abstract] [Full Text] [Related]
9. Impacts and interactions of PDGFRB, MMP-3, TIMP-2, and RNF213 polymorphisms on the risk of Moyamoya disease in Han Chinese human subjects.
Wang X; Zhang Z; Liu W; Xiong Y; Sun W; Huang X; Jiang Y; Ni G; Sun W; Zhou L; Wu L; Zhu W; Li H; Liu X; Xu G
Gene; 2013 Sep; 526(2):437-42. PubMed ID: 23769926
[TBL] [Abstract][Full Text] [Related]
10. Moyamoya Disease and Spectrums of RNF213 Vasculopathy.
Bang OY; Chung JW; Kim DH; Won HH; Yeon JY; Ki CS; Shin HJ; Kim JS; Hong SC; Kim DK; Koizumi A
Transl Stroke Res; 2020 Aug; 11(4):580-589. PubMed ID: 31650369
[TBL] [Abstract][Full Text] [Related]
11. Frequency and significance of rare RNF213 variants in patients with adult moyamoya disease.
Jang MA; Chung JW; Yeon JY; Kim JS; Hong SC; Bang OY; Ki CS
PLoS One; 2017; 12(6):e0179689. PubMed ID: 28617845
[TBL] [Abstract][Full Text] [Related]
12. Identification of RNF213 as a susceptibility gene for moyamoya disease and its possible role in vascular development.
Liu W; Morito D; Takashima S; Mineharu Y; Kobayashi H; Hitomi T; Hashikata H; Matsuura N; Yamazaki S; Toyoda A; Kikuta K; Takagi Y; Harada KH; Fujiyama A; Herzig R; Krischek B; Zou L; Kim JE; Kitakaze M; Miyamoto S; Nagata K; Hashimoto N; Koizumi A
PLoS One; 2011; 6(7):e22542. PubMed ID: 21799892
[TBL] [Abstract][Full Text] [Related]
13. Rare variants of RNF213 and moyamoya/non-moyamoya intracranial artery stenosis/occlusion disease risk: a meta-analysis and systematic review.
Liao X; Deng J; Dai W; Zhang T; Yan J
Environ Health Prev Med; 2017 Nov; 22(1):75. PubMed ID: 29165161
[TBL] [Abstract][Full Text] [Related]
14. RNF213 polymorphism and Moyamoya disease: A systematic review and meta-analysis.
Ma J; Liu Y; Ma L; Huang S; Li H; You C
Neurol India; 2013; 61(1):35-9. PubMed ID: 23466837
[TBL] [Abstract][Full Text] [Related]
15. The association between the ring finger protein 213 (RNF213) polymorphisms and moyamoya disease susceptibility: a meta-analysis based on case-control studies.
Sun XS; Wen J; Li JX; Lai R; Wang YF; Liu HJ; Sheng WL
Mol Genet Genomics; 2016 Jun; 291(3):1193-203. PubMed ID: 26847828
[TBL] [Abstract][Full Text] [Related]
16. MMD-associated
Bhardwaj A; Banh RS; Zhang W; Sidhu SS; Neel BG
Life Sci Alliance; 2022 May; 5(5):. PubMed ID: 35135845
[TBL] [Abstract][Full Text] [Related]
17. Meta-analysis of the association between RNF213 polymorphisms and clinical features of moyamoya disease in Asian population.
Jiang X; Liu L; Ai S; Xie X; Deng J; Jiang Z; Teng B; Liu C; Huang H
Clin Neurol Neurosurg; 2023 Aug; 231():107801. PubMed ID: 37267801
[TBL] [Abstract][Full Text] [Related]
18. Rare and Low-Frequency Variants in RNF213 Confer Susceptibility to Moyamoya Syndrome Associated with Hyperthyroidism.
Nomura S; Akagawa H; Yamaguchi K; Ishikawa T; Kawashima A; Kasuya H; Mukawa M; Nariai T; Maehara T; Okada Y; Kawamata T
World Neurosurg; 2019 Jul; 127():e460-e466. PubMed ID: 30922903
[TBL] [Abstract][Full Text] [Related]
19. Association between the rs112735431 polymorphism of the RNF213 gene and moyamoya disease: A case-control study and meta-analysis.
Huang Y; Cheng D; Zhang J; Zhao W
J Clin Neurosci; 2016 Oct; 32():14-8. PubMed ID: 27515544
[TBL] [Abstract][Full Text] [Related]
20. Systematic Validation of RNF213 Coding Variants in Japanese Patients With Moyamoya Disease.
Moteki Y; Onda H; Kasuya H; Yoneyama T; Okada Y; Hirota K; Mukawa M; Nariai T; Mitani S; Akagawa H
J Am Heart Assoc; 2015 May; 4(5):. PubMed ID: 25964206
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
